Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. EBITDA 2009–2025
Neurocrine Biosciences Inc. annual/quarterly ebitda history and growth rate from 2009 to 2019. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Neurocrine Biosciences Inc. ebitda for the quarter ending March 31, 2019 was -99.4 M, a 171.23% increase year-over-year.
- Neurocrine Biosciences Inc. ebitda for the twelve months ending March 31, 2019 was -236.1 M, a 713.33% increase year-over-year.
- Neurocrine Biosciences Inc. annual ebitda for 2018 was 40.8 M, a 131.66% decrease from 2017.
- Neurocrine Biosciences Inc. annual ebitda for 2017 was -129.0 M, a 11.62% decrease from 2016.
- Neurocrine Biosciences Inc. annual ebitda for 2016 was -145.9 M, a 56.58% increase from 2015.
- Neurocrine Biosciences Inc. annual ebitda for 2015 was -93.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neurocrine Biosciences Inc. EBITDA — FAQ
Neurocrine Biosciences Inc. (NBIX) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's ebitda history?
The chart and table above show Neurocrine Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.